THG HANOVER INSURANCE GROUP, INC. Insider Trading

EVP Bryan J Salvatore sells 16,394 shares of THG at $185.76 for $3.0M; retains 29,069 shares post-transaction.

Bryan J Salvatore sold 16,394 shares representing -36.1% of his pre-transaction holdings, reducing his stake from 45,463 shares to 29,069 shares at $185.76 per share. The sale occurred when the stock is trading -6.3% from its 52-week high of $199.59, and his cross-ticker track record shows a 90d well-timed rate of 0.00% across 6 prior sells. At THG specifically, his 5 prior sales each showed positive 90-day returns (ranging from +2.0% to +3.0%), indicating those prior sales were not well-timed as the stock rose after each sell. THG trades at a P/E of 9.07 with recent quarterly revenue of $1,701,400,000.00 and annual revenue growth of +5.7%, providing fundamental context for evaluating the trade against market valuation.

EVP Dennis Kerrigan sells 6,262 THG shares at $192.99; retains 11,987 shares post-transaction

Dennis Francis Kerrigan, Executive Vice President, sold 6,262 shares of Hanover Insurance Group at $192.99 on 2026-05-20, reducing his holdings by 34.3% to 11,987 shares. The sale occurred at a price 2.0% below the 52-week high of $199.59, while the stock has advanced 8.2% over the prior 30 days and 11.2% over 90 days. The company trades at a P/E of 9.49 with recent quarterly revenue of $1,701,400,000.00 and net income of $186,800,000.00, reflecting solid fundamentals. The transaction represents a substantial reduction in his stake, though retention of 11,987 shares indicates continued material ownership in the firm.

Denise Lowsley (EVP, Hanover Insurance) sold 4,175 shares for $800,472.75 on 2026-05-14, cutting holdings by 51.8%

Denise Lowsley executed 2 separate sales on 2026-05-14, selling 4,175 shares at $115.35 and 4,175 shares at $191.73, totaling $800,472.75 and reducing her holdings from 8,057 shares to 3,882 shares. Her prior sale at THG on 2025-08-01 posted 30-day +3.2% and 90-day +1.2% returns. The stock is currently at $194.64, within 0.7% of its 52-week high of $193.32, with 30-day and 90-day gains of +9.9% and +13.3% respectively. Lowsley's cross-ticker track record shows 0 of 1 prior sells were well-timed at the 90-day mark, with an average 90-day return after sells of +1.2%.

EVP Richard Lavey sold 24,420 shares at blended average $178.92, reducing stake by 44.2% to 30,773 shares remaining

Hanover Insurance EVP Richard Lavey executed 6 separate sales totaling 24,420 shares for $4,369,156.01 on 2026-02-05, reducing his shareholding by 44.2% from 55,193 to 30,773 shares. The transaction prices ranged from $178.05 to $179.83, with a blended average of $178.92, occurring when the stock is -5.5% from its 52-week high of $186.22. His cross-ticker track record shows prior sells averaged +13.2% returns over 90 days with a 0.00% well-timed rate, indicating his past sells have been poorly timed as the stock subsequently rose. At the same ticker (THG), his 4 prior sells in August 2024 all generated positive 90-day returns (ranging 12.2% to 14.1%), again reflecting poorly-timed execution with no instances where the stock declined after his sales. This large reduction in holdings occurs amid fundamentals showing a P/E of 9.91 with 4.1% annual revenue growth and $178.7M in quarterly net income on $1.7B revenue.

EVP Lowsley Denise sold 5,626 shares of THG at $168.15 on 2025-08-01, reducing holdings to 5,119 shares (-52.4%).

Lowsley Denise, Executive Vice President of Hanover Insurance Group, sold 5,626 shares (5.6K shares) valued at $946,011.90 ($946.0K) in a single transaction, halving her stake from 10,745 shares to 5,119 shares. The sale occurred at $168.15, approximately 1.8% below the current price of $171.18 and within a relatively tight range near the 52-week high of $178.04. Against broader context, THG trades at a P/E of 11.03 on annual revenue of $1.7B and net income of $157.1M, with a market cap of $6.1B; the stock has appreciated 4.4% over the prior 30 days and 2.5% over 90 days. The scale of the reduction—52.4% of pre-transaction holdings—represents a material shift in her personal position but does not indicate company-wide insider selling or an evident change in management's broader assessment of value.

THG EVP Salvatore sold 10,526 shares in 3 transactions for $1,753,605.01 on 2025-05-07; holds 25,863 post-sale.

Salvatore Bryan J, Executive Vice President at Hanover Insurance Group, executed 3 separate sales totaling 10,526 shares for $1,753,605.01 on 2025-05-07, reducing his holdings by -28.9% to 25,863 shares. The sales occurred at prices ranging from $166.12 to $167.76 per share (blended average $166.60), close to the current price of $166.24 and within the 52-week range of $120.84–$175.14. His same-ticker prior sales in March 2025 showed modest near-term positive returns (30-day returns of +1.4% to +2.5%), though these outcomes remain incomplete at the 90-day measurement point. The transaction is sized at approximately 28.9% of his pre-transaction holdings, representing a substantial reduction in equity exposure for an executive officer at a company with solid fundamentals (P/E 13.62, $1.6B quarterly revenue, +4.1% annual growth).

THG CEO John C Roche sells 8,906 shares ($1.6M) at $175.17; retains 124.4K shares post-sale

John C Roche, President and CEO of Hanover Insurance Group, sold 8,906 shares on 2025-04-01 for $1,560,064.02, reducing his holdings from 133.3K to 124.4K shares (−6.7%). The sale occurred at $175.17, near the 52-week high of $175.14, with the stock at +0.0% from its peak and +14.9% over 90 days. His cross-ticker track record shows 3 prior open-market sells averaging +1.9% 30-day returns post-sale; his same-ticker history at THG consists of three prior sales on 2025-03-03, each with measurable positive 30-day returns (+2.5%, +1.9%, +1.4%), though the 90-day outcomes remain unmeasurable. The company trades at a P/E of 8.32 with 4.1% annual revenue growth and $1.6B quarterly revenue. No scheduled trading plan FLAGS are indicated, leaving the discretionary nature of this sale as a contextual factor for monitoring, but the modest reduction in a substantial remaining position does not indicate any wholesale portfolio shift.

EVP Salvatore Bryan J sells 10,526 shares for $1,811,530.90 via scheduled 10b5-1 plan at THG

Salvatore Bryan J, Executive Vice President of Hanover Insurance Group, executed 3 separate sales totaling 10,526 shares for $1,811,530.90 on 2025-03-03 at blended average price of $172.10. The transaction was conducted under a pre-arranged 10b5-1 trading plan adopted on 2024-11-27, meaning the sale was scheduled rather than discretionary. Post-transaction holdings stand at 25,835 shares, representing a 28.9% reduction from pre-transaction levels of 36,361 shares. As a scheduled disposition under Rule 10b5-1, this transaction carries no timing signal and reflects a planned execution rather than an active market judgment by the insider.

THG CEO Roche sells 10,706 shares in 3 transactions for $1,842,541.06 on 2025-03-03

John C. Roche, President and CEO of Hanover Insurance Group, executed three separate sales totaling 10,706 shares for $1,842,541.06 on March 3, 2025, at prices ranging from $170.91 to $172.66. Following the sales, Roche retains 124,277 shares, representing a 7.9% reduction in his pre-transaction holdings of 134,983 shares. The transaction occurred near the stock's 52-week high of $173.00 and follows a strong 30-day price advance of 10.8%, placing the stock at elevated valuation levels. The company trades at a P/E of 8.06 with positive 90-day momentum (+3.3%) and recent quarterly revenue of $1,565,300,000.00, but this filing captures a single discrete event rather than evidence of a pattern of activity.

EVP Jeffrey M. Farber sold 6,987 shares at blended avg $165.27 for $1,154,731.50 on THG; holds 42,090 post-sale.

Jeffrey M. Farber, Executive Vice President at Hanover Insurance Group, executed 2 separate sales totaling 6,987 shares for $1,154,731.50 on 2024-11-27 and 2024-11-29 at prices near the 52-week high of $165.01. The transaction reduced his holdings by 14.2%, from 49,077 to 42,090 shares, leaving him with meaningful retained equity of 42.1K shares. This sale occurs within a pattern of frequent selling activity at THG—Farber has executed 5 prior trades at this ticker in November alone (2024-11-08 through 2024-11-18), all sales. The stock has advanced 9.9% over 30 days and 10.4% over 90 days, and trades at a reasonable valuation (P/E 16.00) with solid fundamentals (revenue $1.6B, net income $102.1M, annual growth +9.6%). Absent any disclosed materialization of risk or scheduled plan disclosure, the concentrated pattern of November sales warrants investor attention to determine whether these reflect planned liquidity or a signal from management.